ARAVIVE, INC Shares Outstanding 2013-2021 | ARAV

ARAVIVE, INC shares outstanding from 2013 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
ARAVIVE, INC Annual Shares Outstanding
(Millions of Shares)
2020 16
2019 12
2018 7
2017 6
2016 5
2015 5
2014 3
2013 0
2012 0
ARAVIVE, INC Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 20
2021-03-31 18
2020-12-31 16
2020-09-30 16
2020-06-30 16
2020-03-31 15
2019-12-31 12
2019-09-30 11
2019-06-30 11
2019-03-31 11
2018-12-31 7
2018-09-30 6
2018-06-30 6
2018-03-31 6
2017-12-31 6
2017-09-30 6
2017-06-30 6
2017-03-31 6
2016-12-31 5
2016-09-30 5
2016-06-30 5
2016-03-31 5
2015-12-31 5
2015-09-30 5
2015-06-30 5
2015-03-31 5
2014-12-31 3
2014-09-30 4
2014-06-30 4
2014-03-31 0
2013-12-31 0
2013-09-30 0
2013-06-30 0
2013-03-31 0
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.077B $0.006B
Aravive Inc. is a biotechnology company. It develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. Aravive Inc. is based in TX, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.460B 8.55
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.211B 20.68
Biohaven Pharmaceutical Holding (BHVN) United States $8.952B 0.00
Emergent Biosolutions (EBS) United States $2.717B 6.55
Arcus Biosciences (RCUS) United States $2.502B 0.00
Myovant Sciences (MYOV) United Kingdom $1.906B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.820B 0.00
Zymeworks (ZYME) Canada $1.088B 0.00
Ambrx Biopharma (AMAM) United States $0.513B 0.00
SQZ Biotechnologies (SQZ) United States $0.343B 0.00
Enzo Biochem (ENZ) United States $0.159B 15.57